Members of Congress laid into a notorious pharmaceutical executive on Thursday for his high-profile drug price hikes, but some of those same legislators own stock in companies that are fighting efforts to rein in drug prices.
A top Treasury Department watchdog defended his investigation into the targeting of conservative groups by the Internal Revenue Service.
A Minnesota pastor who blew the whistle on a multi-million dollar fraud testified before Congress about the federal authorities who allegedly threw out the case for political purposes.
Executive agencies did not prepare for the sequester despite knowing about impending cuts for over a year and a half, a congressional hearing on Tuesday afternoon revealed.
A House Oversight subcommittee rebuked the Treasury official who oversees executive pay for federally supported companies at a hearing on Tuesday.
Three different economic experts testified before the House Oversight and Government Reform Committee’s Subcommittee on Economic Growth, Job Creation, and Regulatory Affairs on Thursday afternoon during a heated and contentious hearing.